|
Originally published In Press as doi:10.1074/jbc.M000808200 on May 18, 2000
J. Biol. Chem., Vol. 275, Issue 32, 24977-24983, August 11, 2000
Tau Phosphorylation at Serine 396 and Serine 404 by Human
Recombinant Tau Protein Kinase II Inhibits Tau's Ability to Promote
Microtubule Assembly*
David B.
Evans,
Kenneth B.
Rank,
Keshab
Bhattacharya,
Darrell R.
Thomsen,
Mark E.
Gurney, and
Satish K.
Sharma
From the Pharmacia Corporation, Kalamazoo, Michigan
49007
In Alzheimer's disease, hyperphosphorylated tau
is an integral part of the neurofibrillary tangles that form within
neuronal cell bodies and fails to promote microtubule assembly.
Dysregulation of the brain-specific tau protein kinase II is reported
to play an important role in the pathogenesis of Alzheimer's disease
(Patrick, G. N., Zukerberg, L., Nikolic, M., De La Monte, S.,
Dikkes, P., and Tsai, L.-H. (1999) Nature 402, 615-622).
We report here that in vitro phosphorylation of human tau
by human recombinant tau protein kinase II severely inhibits the
ability of tau to promote microtubule assembly as monitored by tubulin
polymerization. The ultrastructure of tau-mediated polymerized tubulin
was visualized by electron microscopy and compared with phosphorylated
tau. Consistent with the observed slower kinetics of tubulin
polymerization, phosphorylated tau is compromised in its ability to
generate microtubules. Moreover, we show that phosphorylation of
microtubule-associated tau results in tau's dissociation from the
microtubules and tubulin depolymerization. Mutational studies with
human tau indicate that phosphorylation by tau protein kinase II at
serine 396 and serine 404 is primarily responsible for the functional
loss of tau-mediated tubulin polymerization. These in vitro
results suggest a possible role for tau protein kinase II-mediated tau
phosphorylation in initiating the destabilization of microtubules.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Pharmacia Corp.,
Protein Science, 7240-267-117, Kalamazoo, MI 49007. Tel.: 616-833-9413; Fax: 616-833-1488; E-mail: satish.k.sharma@am.pnu.com.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Amniai, P. Barbier, A. Sillen, J.-M. Wieruszeski, V. Peyrot, G. Lippens, and I. Landrieu
Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but not binding to microtubules
FASEB J,
April 1, 2009;
23(4):
1146 - 1152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. N. Green, J. S. Steffan, H. Martinez-Coria, X. Sun, S. S. Schreiber, L. M. Thompson, and F. M. LaFerla
Nicotinamide Restores Cognition in Alzheimer's Disease Transgenic Mice via a Mechanism Involving Sirtuin Inhibition and Selective Reduction of Thr231-Phosphotau
J. Neurosci.,
November 5, 2008;
28(45):
11500 - 11510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Bandyopadhyay, G. Li, H. Yin, and J. Kuret
Tau Aggregation and Toxicity in a Cell Culture Model of Tauopathy
J. Biol. Chem.,
June 1, 2007;
282(22):
16454 - 16464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Caccamo, S. Oddo, L. X. Tran, and F. M. LaFerla
Lithium Reduces Tau Phosphorylation but Not A{beta} or Working Memory Deficits in a Transgenic Model with Both Plaques and Tangles
Am. J. Pathol.,
May 1, 2007;
170(5):
1669 - 1678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kitazawa, S. Oddo, T. R. Yamasaki, K. N. Green, and F. M. LaFerla
Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease
J. Neurosci.,
September 28, 2005;
25(39):
8843 - 8853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Li, H. Yin, and J. Kuret
Casein Kinase 1 Delta Phosphorylates Tau and Disrupts Its Binding to Microtubules
J. Biol. Chem.,
April 16, 2004;
279(16):
15938 - 15945.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Ahn, A. Musacchio, M. Mapelli, J. Ni, L. Scinto, R. Stein, K. S. Kosik, and L.-A. Yeh
Development of an Assay to Screen for Inhibitors of Tau Phosphorylation by Cdk5
J Biomol Screen,
March 1, 2004;
9(2):
122 - 131.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kesavapany, K.-F. Lau, S. Ackerley, S. J. Banner, S. J. A. Shemilt, J. D. Cooper, P. N. Leigh, C. E. Shaw, D. M. McLoughlin, and C. C. J. Miller
Identification of a Novel, Membrane-Associated Neuronal Kinase, Cyclin-Dependent Kinase 5/p35-Regulated Kinase
J. Neurosci.,
June 15, 2003;
23(12):
4975 - 4983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Takahashi, T. Saito, S.-i. Hisanaga, H. C. Pant, and A. B. Kulkarni
Tau Phosphorylation by Cyclin-dependent Kinase 5/p39 during Brain Development Reduces Its Affinity for Microtubules
J. Biol. Chem.,
March 14, 2003;
278(12):
10506 - 10515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Sun, H. Y. Qureshi, P. W. Cafferty, K. Sobue, A. Agarwal-Mawal, K. D. Neufield, and H. K. Paudel
Glycogen Synthase Kinase-3beta Is Complexed with Tau Protein in Brain Microtubules
J. Biol. Chem.,
March 29, 2002;
277(14):
11933 - 11940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Shanavas and S. Ch. Papasozomenos
tau kinases in the rat heat shock model: Possible implications for Alzheimer disease
PNAS,
December 19, 2000;
97(26):
14139 - 14144.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|